Badoual C - Search Results

1

[The "immune checkpoints", how does it work].

Granier C, Soumelis V, Mandavit M, Gibault L, Belazzoug R, de Guillebon E, Badoual C, Tartour E, Roussel H. Granier C, et al. Among authors: badoual c. Ann Pathol. 2017 Feb;37(1):18-28. doi: 10.1016/j.annpat.2016.12.007. Epub 2017 Feb 1. Ann Pathol. 2017. PMID: 28160999 French.

2

Identification and characterisation of a group of cervical carcinoma patients with profound downregulation of intratumoral Type 1 (IFNgamma) and Type 2 (IL-4) cytokine mRNA expression.

Gey A, Kumari P, Sambandam A, Lecuru F, Cassard L, Badoual C, Fridman C, Nagarajan B, Fridman WH, Tartour E. Gey A, et al. Among authors: badoual c. Eur J Cancer. 2003 Mar;39(5):595-603. doi: 10.1016/s0959-8049(02)00839-0. Eur J Cancer. 2003. PMID: 12628838

3

[Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].

Benchetrit F, Gazagne A, Adotevi O, Haicheur N, Godard B, Badoual C, Fridman WH, Tartour E. Benchetrit F, et al. Among authors: badoual c. Bull Cancer. 2003 Aug-Sep;90(8-9):677-85. Bull Cancer. 2003. PMID: 14609756 Free article. Review. French.

4

[Phenotypic and functional analysis of T lymphocytes in cancer patients].

Badoual C, Vingert B, Agueznay N, Adotevi O, Haicheur N, Molina T, Bruneval P, Fridman WH, Tartour E. Badoual C, et al. Ann Pathol. 2005 Jun;25(3):211-9. doi: 10.1016/s0242-6498(05)80112-9. Ann Pathol. 2005. PMID: 16230947 Review. French.

5

Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers.

Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E. Badoual C, et al. Clin Cancer Res. 2006 Jan 15;12(2):465-72. doi: 10.1158/1078-0432.CCR-05-1886. Clin Cancer Res. 2006. PMID: 16428488

6

Comprehensive analysis of HLA-DR- and HLA-DP4-restricted CD4+ T cell response specific for the tumor-shared antigen survivin in healthy donors and cancer patients.

Wang XF, Kerzerho J, Adotevi O, Nuyttens H, Badoual C, Munier G, Oudard S, Tu S, Tartour E, Maillère B. Wang XF, et al. Among authors: badoual c. J Immunol. 2008 Jul 1;181(1):431-9. doi: 10.4049/jimmunol.181.1.431. J Immunol. 2008. PMID: 18566409

7

[A disconcerting pleural effusion].

Côté JF, Auriault ML, Boivin JF, Igual J, David-Ouaknine F, Badoual C, Damotte D. Côté JF, et al. Among authors: badoual c. Ann Pathol. 2009 Feb;29(1):40-2. doi: 10.1016/j.annpat.2008.02.001. Epub 2009 Jan 29. Ann Pathol. 2009. PMID: 19233094 French. No abstract available.

8

[Head and neck squamous cell carcinoma: What's new in 2009].

Badoual C, Péré H, Cros J, Roussel H. Badoual C, et al. Ann Pathol. 2009 Sep;29(4):265-73. doi: 10.1016/j.annpat.2009.07.004. Epub 2009 Sep 16. Ann Pathol. 2009. PMID: 19900632 Review. French.

9

Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies.

Badoual C, Sandoval F, Pere H, Hans S, Gey A, Merillon N, Van Ryswick C, Quintin-Colonna F, Bruneval P, Brasnu D, Fridman WH, Tartour E. Badoual C, et al. Head Neck. 2010 Jul;32(7):946-58. doi: 10.1002/hed.21346. Head Neck. 2010. PMID: 20191626 Review.

10

A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients.

Adotevi O, Pere H, Ravel P, Haicheur N, Badoual C, Merillon N, Medioni J, Peyrard S, Roncelin S, Verkarre V, Mejean A, Fridman WH, Oudard S, Tartour E. Adotevi O, et al. Among authors: badoual c. J Immunother. 2010 Nov-Dec;33(9):991-8. doi: 10.1097/CJI.0b013e3181f4c208. J Immunother. 2010. PMID: 20948437 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

237 results

Search Page